DARAPRIM

This brand name is authorized in United States. It is also authorized in Brazil, Estonia, Malta, Mexico, Netherlands, Spain, UK.

Active ingredients

The drug DARAPRIM contains one active pharmaceutical ingredient (API):

1	Pyrimethamine UNII Z3614QOX8W - PYRIMETHAMINE
	Pyrimethamine is an antiparasitic agent. The antiparasitic action of pyrimethamine is due to its specific activity on folic acid metabolism in the Plasmodium and Toxoplasma parasites.
	Read more about Pyrimethamine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DARAPRIM Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BD01	Pyrimethamine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BD Diaminopyrimidines
Discover more medicines within P01BD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	509001301115317, 509013120012403
EE	Ravimiamet	1101373, 1759248
ES	Centro de información online de medicamentos de la AEMPS	19625
GB	Medicines & Healthcare Products Regulatory Agency	40984
MT	Medicines Authority	AA565/15702, AA565/15703
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	40259
NL	Z-Index G-Standaard, PRK	744
US	FDA, National Drug Code	69413-330